NAFDAC MOJISOLA ADEYEYE DRUGS India indian seeks
NAFDAC will be speaking with pre-shipment agents over rejected food exports from foreign ports.
NAFDAC to Benefit from Global Fund’s $933m Grant

The National Agency for Food and Drug Administration and Control (NAFDAC) has gotten approval to access Global Fund’s 2024-2026 grant of $933 million to Nigeria.

The National Agency for the Control of AIDS (NACA) is the principal recipient of the fund.

NAFDAC’s Director General, Prof. Mojisola Adeyeye, announced that the management of the agency’s $2 million component of the outgoing Global Fund 2021-2023 grant was responsible for its further inclusion as a beneficiary of the fund’s 2024-26 grant.

Adeyeye, who spoke at a meeting with the Global Fund and the National Agency for the Control of AIDS (NACA) in Abuja, said through vital support from the Global Fund’s Resilient and Sustainable Systems for Health (GF-RSSH) grant, NAFDAC had been met critical parts of its mandate in safeguarding the nation’s health.

Global Fund and NACA declared NAFDAC’s utilisation of the existing grant satisfactory.

The acting Executive Secretary of the Country Coordinating Mechanism for Global Fund Nigeria, Mr. Ibrahim Olaitan, said the decision to continue the collaboration was due to NAFDAC’s proven transparency and accountability with the outgoing grant.

He said NAFDAC’s management of the grant met all criteria to guarantee its participation in the next grant, adding: “The NAFDAC support is cross-cutting for laboratory strengthening, quality control, and quality assurance for the ATM products.”

Corroborating Global Fund, NACA’s Director General Gambo Aliyu said: “With $2 million, this is remarkable and this is what we want to encourage to see more for the entities we disbursed money to. We want to hold this kind of a meeting to hear from them to tell us what they do. In terms of transparency, Global Fund’s money is very safe with NAFDAC.”

The Global Fund is an international financing institution dedicated to combating HIV/AIDS, Tuberculosis, as well as Malaria and Resilient and Sustainable Systems through support to countries in their efforts to address global health challenges and strengthen health systems.